In this week’s Homerun Slides, we take a look at the beta cell mass and pathogenesis of type 2 diabetes… To download the complete set in PowerPoint format, just use this link: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 4 …
Read More »Yearly Archives: 2015
The Present and Future of Insulin Therapy Part 3
In this week’s Homerun Slides, we continue to focus on insulin therapy in the treatment of type 2 diabetes with a look at the natural histories of type 2 and beta cell failure in type 2 diabetes …
Read More »The Present and Future of Insulin Therapy Part 2
In this week’s Homerun Slides, we take a look at the current therapy for type 2 diabetes…
Read More »George Bakris, MD: SGLT2 Mechanism for BP Reduction Part 1 of 6
George Bakris, MD, sits down with Diabetes in Control Publisher Steve Freed to discuss the effects of SGLT2 drugs on the kidneys and how it can be effective at dispelling sodium and lowering the blood pressure. He also talks about another method of blood pressure monitoring that gives a more …
Read More »Editor’s Note, DCMS #253
Every day, more and more of our patients start on insulin. In past years, most of these patients were started on basal insulin by their primary care prescriber and then titrated up. However, when it came to adding on meal time insulin, they we’re often referred to an endocrinologist. Now …
Read More »Case Study: The Importance of Patient-Centered Therapy
A 59 YOF is recently discharged from hospital after an allergic reaction to an anesthesia induction agent. She was placed on high-dose steroid for the reaction while she was in the hospital. Patient had completed her steroid tapering dose 2 months prior to her visit to endocrinology clinic today due to high blood glucose (a1c 8.9%). Past medical history included: hypertension, hyperlipidemia, atrial fibrillation, obesity and diabetes for 7 years. She was well controlled on metformin 1000mg BID before...
Read More »Book Review: Practical Insulin: A Handbook for Prescribing Providers
Our Doctor of Pharmacy Candidate from LECOM College of Pharmacy, Christina Dowd, has reviewed a new book from the ADA and found that it is a good read for you. See what she has to say.
Read More »Low Birth Weight May Be Linked to a Higher Type 2 Diabetes Risk in Adulthood
In addition to lifestyle, a new study suggests birthweight may play a role in a person’s risk for developing type 2 diabetes… A recent Harvard study was published in BMJ involving nearly 150,000 men and women without diabetes at baseline who were followed for 20-30 years. Researchers prospectively looked at …
Read More »New Study Suggests Pioglitazone Does Not Increase Bladder Cancer Risk
Increased risk for prostate and pancreatic cancer associated with use of drug… A recent study published in JAMA looked at long-term data from nearly 200,000 diabetes patients to revisit the debate of whether pioglitazone significantly increases the risk of bladder cancer in patients or not. In the process, researchers also …
Read More »First Non-Surgical Weight Loss Procedure for Mild-to-Moderate Obesity
ReShape Dual Balloon helping patients to achieve life-changing weight loss without surgery… A new non-surgical weight loss option is now available. The FDA has approved ReShape Integrated Dual Balloon System which is the first non-surgical weight loss procedure for people with mild-to-moderate obesity. ReShape is a dual balloon mounted on …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.